Annual Report 2023
Wilmington plc announces its results for the year ended 30 June 2023.
Key highlights include 9% revenue growth from continuing businesses, with our training and education division achieved a particularly impressive 15% growth in organic revenue, while our intelligence brands reported 3% growth.
The increased revenues and a continued focus on operational efficiency and cost management resulted in adjusted PBT growth from continuing businesses of 30%.
Mark Milner, Chief Executive Officer:
“Wilmington has transformed over the last four years to become a digital first business, focussed on the attractive GRC sector, reinvigorating and innovating our products and services to develop deeper and longer-term relationships with clients, focussed on the Intelligence and Training & Education markets, with a growth mindset at our core”
"Both divisions and our teams are performing strongly. We continued to focus on consolidating our already strong presence in the large, growing and rapidly evolving GRC markets.”
View Annual Report (PDF 9.09MB)
View Annual Report (ESEF XHTML with iXBRL viewer)
![Sale of UK Healthcare Business](https://wilmingtonplc.com/sites/default/files/styles/news_270_152_/public/2024-06/CD-18274_0.jpg.webp?itok=mAZ8HN2G)
News
Sale of UK Healthcare Business
Wilmington has completed the sale of its UK Healthcare business to Inspirit Capital.
Read More![Sale of APM International](https://wilmingtonplc.com/sites/default/files/styles/news_270_152_/public/2024-06/CD-18274_0.jpg.webp?itok=mAZ8HN2G)
News
Sale of APM International
Wilmington plc, has sold its French healthcare business, APM International to Philia Medical Editions SAS, a subsidiary of Europa Group.
Read More![Congratulations FRA!](https://wilmingtonplc.com/sites/default/files/styles/news_270_152_/public/2024-05/Untitled%20design%20%285%29.jpg.webp?itok=Tsm8n93G)
News
Congratulations FRA!
Congratulations to the FRA team in the US who last week successfully certified to the ISO Event Sustainability Standard (ISO20121), with no audit findings.
Read More